Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IgG4 and hyposensitization.

S Van der Zee1, R C Aalberse

  • 1Central Laboratory of the Netherlands, Red Cross Blood Transfusion Service, Amsterdam.

New England and Regional Allergy Proceedings
|November 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation.

BMC neurology·2024
Same author

Does a strong IgG response precede allergic sensitization?

Allergy·2018
Same author

Repeated vaccination with tetanus toxoid of plasma donors with pre-existing specific IgE transiently elevates tetanus-specific IgE but does not induce allergic symptoms.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018
Same author

EAACI Molecular Allergology User's Guide.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2016
Same author

Moving from peanut extract to peanut components: towards validation of component-resolved IgE tests.

Allergy·2013
Same author

Food allergens.

Environmental toxicology and pharmacology·2011

The exact mechanism of hyposensitization therapy remains unclear. While allergen-blocking antibodies, particularly IgG4, play a role, other factors likely contribute to its effectiveness in allergy treatment.

Area of Science:

  • Immunology
  • Allergy Research
  • Therapeutic Mechanisms

Background:

  • The precise mechanisms underlying hyposensitization therapy are not fully understood.
  • Allergen-blocking antibodies are suspected to contribute, especially in insect venom allergies, but their exact role and other operative mechanisms require elucidation.

Purpose of the Study:

  • To investigate the potential roles of different antibody classes, including IgG4, in the efficacy of hyposensitization.
  • To explore whether IgG4 is the exclusive allergen-blocking antibody in immediate type allergy.
  • To examine the broader biological significance of IgG4 production during prolonged antigenic exposure.

Main Methods:

  • Analysis of antibody production during hyposensitization therapy.
  • Evaluation of the role of specific antibody isotypes (IgG1, IgG4) in allergic responses.

Related Experiment Videos

  • Assessment of immune complex formation and complement fixation.

    • Main Results:

    • Suppression of specific IgE antibody production does not appear to be a primary factor in current hyposensitization treatments.
    • IgG4 is identified as a major allergen-blocking antibody, though not exclusively.
    • The production of non-complement fixing IgG4 antibodies may prevent immune complex diseases.

    Conclusions:

    • Hyposensitization involves complex immunological mechanisms beyond simple IgE suppression.
    • IgG4 antibodies likely play a significant role in blocking allergens and preventing immune complex-related disorders during therapy.
    • The shift towards IgG4 production may be a protective mechanism against adverse effects of prolonged antigen exposure.